Wednesday, October 27, 2010
For Personalized Medicine CPMC is the Gold Standard Study
Posted by
Steve Murphy MD
at
7:43 PM
1 comments
Labels: american journal of human genetics, coriell personalized medicine collaborative, cpmc, Gene Sherpas, personalized medicine, Rita Rubin, USA Today
Tuesday, September 15, 2009
Tell Me, How do you feel now? Sherpa's RX
One thing is for sure. In a recent poll of members of the AMA, granted a pretty skewed poll as tons of AMA members cut up their cards this year........random sample of 6000 physicians from the American Medical Association (AMA) Physician Masterfile, which includes current data on all U.S. physicians.
Excluded were, residents and doctors in US territories. From this data in the New England Journal of Medicine, Keyhani et al found some interesting things. The biggest of these is that a majority of physicians are for a governmental option WITH private options.
Not a surprise, this is what ALREADY EXISTS.
From the study......
"Survey respondents were asked to indicate which of three options for expanding health insurance coverage they would most strongly support:
1. public and private options, providing people younger than 65 years of age the choice of enrolling in a new public health insurance plan (like Medicare) or in private plans
2. private options only, providing people with tax credits or subsidies, if they have low income, to buy private insurance coverage, without creating a new public plan.
3. a public option only, eliminating private insurance and covering everyone through a single public plan like Medicare.
We also assessed the level of physician support for a proposal that would enable adults between the ages of 55 and 64 years to buy into the current Medicare program — a strategy that the Senate Finance Committee has proposed."
But what pisses me off about the article is how it is written....take a listen....
"Physicians in every census region showed majority support for a public option, with percentages in favor ranging from 58.9% in the South to 69.7% in the Northeast. Practice owners were less likely than nonowners to support a public option (59.7% vs. 67.1%, P<0.001),>majority still supported it."
No caveats for the fact that DOCTORS ONLY SUPPORT A PUBLIC OPTION IFF there exists a private industry as well.
What these jokers don't say is precisely that point. Which is why, the press will publish "A majority of doctors support a Public Plan" which may sound like they support single payer.....
They don't. In fact, 3 times as many support a private only plan than a public only plan!!!!
They do acknowledge limitations
"Some limitations of our study deserve comment. First, our response rate was 43.2%, which is modest, though typical of the most recent national physician surveys and surveys in general.
There were no significant differences between survey respondents and nonrespondents in important characteristics, such as specialty, practice location, and practice type.
Second, physicians’ opinions about strategies for expanding health insurance coverage may have evolved during the period of data collection, given the intensive press coverage of the issues."
But in the end, they never, ever mention the fact that a near THIRD of physicians support a private ONLY system and that this number is 3 times the physicians who support a government ONLY plan like Canada or the UK. Thus placing those progressives who demand such, clearly outside of the mainstream of most physicians.....
The only true way to save costs is to start using science and personalized medicine. You will not save costs by covering more people. In fact, I argue that there is no science which truly extols the benefit of enhanced coverage. What should be enhanced is catastrophic coverage.
What bankrupts people? Catastrophe, not a URI.
If you want to nationalize/universalize coverage, stick with catastrophic care. That would make sure everyone was covered when HUGE bills hit.
I am certain this plan would be extremely useful. Enroll everyone in this system and pay out when catastrophe strikes. It works for life insurance. Leave the small time players alone and focus on hospitalization costs, etc.
Continue funding HPSA and increase the loan repayment to 300k over 3 years rather than 85 over 3 years. Watch the doctors come then.......
Give tax subsidies for people who pay for URIs etc or traditional health insurance, which now should cost less as the government/taxpayer absorbs the catastrophic costs.........
That should keep everyone covered and help out with the uninsured. We all know that the major cost to hopsitals is the "self pay" patient with disseminated echinococcus or HIV or esophageal cancer or heart attack.
As for the government and medicare, if you just had a huge boost in revenue by new people coming on board for catastrophic care (To be read as, not pay out for most, and pay out later for some) you could help that insolvency thingy........
The Sherpa Says: Personalized Medicine is a key, rational thinking is the LOCK! I know, my wife just had an ER visit, the hospital charged 6168.00 USD, the insurance paid 800 USD. If she didn't have an insurer protecting her from gouging, she would have had to pay 6168.00 USD. I see it both ways....
Posted by
Steve Murphy MD
at
5:31 AM
0
comments
Labels: barack obama, drudgereport, healthcare reform, obamacare, personalized medicine
Tuesday, July 14, 2009
Why SB482 is bust. I am amazed by smart people.
If any of you were on the receiving end of my email blast, bear with me. I have a few points to make this morning. A coupla weeks ago, June 24th to be precise.......23andSergey reposted a tweet which really got my attention......
The original tweet was "@23andMe BTW, you saved me $25 for a CF test - used my and spouse's 23 results instead. Thx!"
The user is a really super smart CEO of a company.
After Daniel MacArthur and I protested, 23andSergey pulled down the post........Normally not a big deal, but then came a tweet for me which really had me even further convinced of some issues with DTC
"@hh Really, how so? Our fertility doc says "either of you been tested as a carrier of CF?", yes, both know status via our @23andme."
Do they really know?
No. Truth be told, the delta508 mutation is not exactly the gold standard for carrier screening.....and what the hell? Carrier screening? Isn't that medicine?
Which brings me right down to it........State Bill 482 in essence says that these DTC genomics companies aren't really doing testing. They are only applying a mathematical algorithm to determine risk...........
Could you please tell me what algorithm is used to say you are or you are not a delta508 carrier in the CFTR gene?
Here's another question.
What algorithm are you using to tell people whether or not they have Ashkenazi Jewish Founder Mutations in BRCA genes?
The answer is, they are speaking out of both sides of their mouth. These companies are intellectually dishonest and are looking to pull a fast one here.......and their lack of care for customer or patient safety and health is amazing.
When they pulled that CF retweet, did they post a tweet which says "23andSergey services are not to be used for medicine, and carrier screening is part of medicine"
The short answer.
No.
The long answer, why turn away a customer base who is inferring that it can be used?
I was quoted at the bottom of a San Jose Mercury News article the other day I am an Internist BTW.......
But my point is this, in the world of scandal in politics and lack of transparency, shouldn't we be asking why a company who wants to do this research revolution but won't have an IRB, a company who wants to "Be regulated" buyt by their own rules, a company who has deep ties to a company whose bailiwick is data mining and archiving, a company who performs medical type tests and infers that they can be used as such (despite the fine print)......shouldn't they be held to some sort of standard here?
Are we in the field of genetics so desperate for attention that we let these companies slide in their own laws and their own rules? Do all ships really rise with the tide? We need to ask ourselves here, is this sort of quick shiftiness and legal manipulation ok for the field of genetics?
What sort of trust does it inspire to know that the laws regulating companies were written by the companies. Less than 10% of all congressmen and senators were ever doctors (for my curious detractors).
Why does the medical field come under fire? Lack of trust. Do we really want another chink in our armour?
Does the entire field of genetics and its amazing discoveries want in its midst a company who is willing to manipulate data, lawmakers and ethics to survive?
What does that say about the field? How desperate are we?
What does accepting them say about us?????
Posted by
Steve Murphy MD
at
4:41 AM
0
comments
Labels: 23andme, barack obama, coriell personalized medicine collaborative, drudgereport, Helix Health of Connecticut, navigenics, personalized medicine
Thursday, February 12, 2009
Prasugrel saves Clopidogrel???
Posted by
Steve Murphy MD
at
4:10 AM
2
comments
Labels: clopidogrel, coriell personalized medicine collaborative, effient, eli lilly, Helix Health of Connecticut, navigenics, personalized medicine, plavix, prasugrel
Thursday, January 24, 2008
Got TT? Stay away from "water pills"
In case you missed it. In the Journal of the American Medical Association a large retrospective analysis of the ALLHAT trial was done. What is the ALLHAT trial? It was an analysis of high blood pressure, treatments and outcomes. In the land of what us physician folk call Landmark Studies, this is a big study.
ALLHAT was a randomized, double-blind, multicenter clinical trial (623 clinical centers) with 42 418 hypertensive participants aged 55 years or older who had 1 or more additional risk factors for cardiovascular disease. ALLHAT was designed to determine if the incidence of fatal coronary heart disease (CHD) and nonfatal myocardial infarction in high-risk hypertensive patients was lower with treatment using each of 3 antihypertensive drug classes: a calcium channel blocker (amlodipine), an ACE inhibitor (lisinopril), and an -adrenergic blocker (doxazosin) compared with treatment using a diuretic (chlorthalidone).
The posthoc analysis using genotypes was performed from 2004-2005. The results are just being published now. What did they genotype?
GenHAT genotyped variants in several hypertension-related genes in 39 114 ALLHAT participants with available DNA, making the study design a post hoc subgroup analysis of a randomized clinical trial. The goal of GenHAT was to understand gene-treatment interactions on CVD outcomes and blood pressure lowering.... There were 38 462 participants with data available for at least 1 variant.
The variant of interest is a gene called NPPA. Studies in animal models have shown that animals which have "minor alleles" for this gene end up with salt provoked hypertension. In addition and possibly more importantly, these patients showed higher risk of horrible disease such as stroke or heart attack.
I will not get into the physiology of high blood pressure today. But suffice it to say that there are several ways to lower the pressure in our arteries. Think of arteries like garden hoses. If there is alot of water in the hose, the pressure is up. If I take that same hose and that same amount of water, then I squeeze the hose. Guess what? The pressure goes up. So if I can lower the amount of water in the hose or dilate the hose to a bigger size, then I can lower the pressure. The "water pill" chlorthalidone removes water, the amlodipine dilates the hose. The Ace-inhibitor removes water indirectly.
Here's where we get a Landmark result for Personalized Medicine:
The NPPA T2238C variant was associated with modification of antihypertensive medication effects on cardiovascular disease and BP. Minor C allele carriers experienced more favorable cardiovascular disease outcomes when randomized to receive a diuretic, whereas TT allele carriers had more favorable outcomes when randomized to receive a calcium channel blocker.
What the hell does this mean? If you carry the TT pair of this NPPA gene, you shouldn't take the diuretic. Unless you want to have a higher risk of stroke.
The Sherpa Says: Despite being a modest elevation in risk, 126%. It is certainly easy enough to change a person's medications to avoid poor outcomes. This is what Personalized Medicine IS. The right diagnosis leading to the right drug for the right person. This is what we do at my offices. Does this come on the Illumina gene chips? SNP database ID rs5065. To my firend Brandon, check this one out!
Posted by
Steve Murphy MD
at
4:04 AM
5
comments
Labels: 23 and me, Helix Health of Connecticut, personalized medicine
Wednesday, January 2, 2008
2008 Here We Come!!!
On the contrary, personalized molecular medicine appears to be at our doorstep.
The Sherpa Says: The conclusions are coming. I think Yoda said it best "Patience" This year will require tremendous amounts of it. Francis Collins tells a joke "There is this woman who is married to a research geneticist. He keeps telling her how great their sex life WILL be." Thank you to a certain unnamed TV news series for thinking of me when covering Personal Genomics. I look forward to our discussions. Does anyone think the New Year's Ball looks like an AAV?
Posted by
Steve Murphy MD
at
8:16 AM
0
comments
Labels: DNA direct, duchenne muscular dystrophy, francis collins, Helix Health of Connecticut, NEJM, New england journal of medicine, personalized medicine
Wednesday, December 19, 2007
Genomics Into the New Year
What will the New Years bring genomics. Well, I have had my ear to the ground and have some ideas.
First the obvious
1. GINA will be passed by hitching a ride on another bill. How sad is that?
2. Navigenics will enter the fray and telemedicine will have a whole new face. What that face will look like is yet to be completely determined.
3. One of these companies will get sued
Next the less obvious
1. Academia will start to market personalized medicine
2. Helix Health of Connecticut will not be the only face to face private (non-Academic center) personalized medicine service...and they will be welcome friends. There are so many out there who need this.
3. Oprah will have her Genome sequenced ( I swear it will happen)...Obama too
Finally the inconceivable
1. Jim Watson will pass from this earth
2. A little unnamed startup will win the X-Prize
3. Mark Cuban will buy the rights to all of 23 and Me's genome database
The Sherpa Says:
To know the future we must look at the past. And if we fail to learn the mistakes from our past, we can always blame our genes. Or at least have the journalists tell us we can.
Posted by
Steve Murphy MD
at
4:15 PM
0
comments
Labels: 23 and me, barack obama, DNA direct, existence genetics, Helix Health of Connecticut, james watson, mark cuban, personalized medicine
Wednesday, December 5, 2007
Delaware Reducing the Gap!
As I had talked about in prior posts Coriell has now officially launched the Delaware Personalized Medicine Project. For all of those genome seekers out there, I suggest that you check out this project.
Who is Coriell? Well in case you have never heard of the HapMap before today....
The Coriell Institute for Medical Research is an internationally known not-for-profit, basic biomedical research institution. The Institute's founder, Lewis L. Coriell, M.D., Ph.D., played a major role in bringing the Salk polio vaccine to the public by using cell cultures to study human viral diseases. The Coriell Institute was founded in 1953.
I initially had contact with the people from Coriell in 2005 at ASHG. This is an amazing group of dedicated individuals who are always carrying genetics forward. The Repositories at Coriell provided support to the Human Genome Project, a world-wide program to map the entire human genome, and to the International HapMap Project, a project to provide an efficient tool to identify disease causing genes.
The Delaware Valley Personalized Medicine Project© is a forward thinking, joint effort involving patient volunteers, physicians, scientists, ethicists and information technology experts whose goal is to better understand the coming impact of genome-informed medical practice and to guide its ethical, legal and responsible implementation.
The study will seek to discover presently unknown genes that elevate a patient's risk of cancer, heart disease and other complex diseases, to understand why patients often respond quite differently to treatments, and to explore how the resulting information can best be viewed and utilized by patients themselves and their physicians in a secure, user-friendly environment.
THIS IS THE MOST IMPORTANT PART!!!!!
All patient volunteers will control their genetic profiles and will be able to determine for themselves whether they wish the information to become part of their personal medical records in the future.
The First Volunteer? A South Jersey Congressman....Maybe they can find the "Crooked Politician Gene"......Just Kidding....sort of :)
The Sherpa Says:
This is exactly what the field of Personalized Medicine needs. Not some project hidden behind fancy marketing and a cool website....or 3 million dollars of seed capital. This project will allow you total control over your genetic information and that is precisely what the public needs. I feel sorry for those who paid to have their SNPs resold at a higher price.
Posted by
Steve Murphy MD
at
4:53 PM
0
comments
Labels: 23 and me, deCODEme, Helix Health of Connecticut, navigenics, personalized medicine
Monday, November 12, 2007
I never realized
Posted by
Steve Murphy MD
at
5:29 PM
2
comments
Labels: 23 and me, celera genomics, Craig Venter genes, Helix Health of Connecticut, nanopore sequencing, navigenics, personal genome, personalized medicine, sequenom
Friday, October 12, 2007
Wylie Coyote? No. Wylie Burke!
Dr. Wylie Burke is Professor and Chair of the Department of Medical History and Ethics at the University of Washington. She is also Principal Investigator of the University of Washington Center for Genomics and Healthcare Equality, an NIH-funded Center of Excellence in Ethical, Legal, and Social Implications (ELSI) Research. Her research addresses the social, ethical and policy implications of genetic information.
"Nevertheless, claims of a new medical paradigm based on genomics merit careful scrutiny. The exhortation to prepare for a “genomics revolution” often assumes that genetic risk is different in kind from other health risks."
"Each new genetic test will need to be evaluated and assessed to demonstrate that the overall health benefits exceed the harms before it is implemented in practice. The fundamental
principle is that genetic risk information will be useful only if it guides more effective, or more cost effective, use of medical interventions than can be achieved without the risk information."
Personalized medicine has always been a component of good medical practice. Genetic tests may provide new tools, but they do not change the fundamental goal of clinicians
to adapt available medical tests and technologies to the individual circumstance of their patients. As genetic tests become widely available, personalized medicine will include
assisting patients to make wise use of genetic risk assessment, taking into account the cautions discussed in this article. When genetic testing is used, the personalized nature
of the care will extend well beyond the patient’s base pair sequences.
The good Dr Burke is pointing to careful clinical care and continuity of care being key to personalized medicine. I agree that not all personalized medicine is genetic. That is why no report printed on a sheet of paper will achieve the goal of personalized medicine.
Posted by
Steve Murphy MD
at
10:10 AM
2
comments
Labels: 23 and me, DNA direct, Helix Health of Connecticut, navigenics, personalized medicine
Sunday, September 9, 2007
Gene Genie and George's Blog
Posted by
Steve Murphy MD
at
6:31 PM
0
comments
Labels: gene genie, george church, personal genome project, personalized medicine
Friday, August 17, 2007
Good Morning America Versus the MDs
Posted by
Steve Murphy MD
at
12:16 PM
0
comments
Labels: coumadin, genetic testing, personalized medicine, tim johnson, warfarin
Thursday, July 26, 2007
Oscar and Predictive, Personalized Death
From the article:
Oscar takes no notice of the woman and leaps up onto the bed. He surveys Mrs. T. She is clearly in the terminal phase of illness, and her breathing is labored. Oscar's examination is interrupted by a nurse, who walks in to ask the daughter whether Mrs. T. is uncomfortable and needs more morphine. The daughter shakes her head, and the nurse retreats. Oscar returns to his work. He sniffs the air, gives Mrs. T. one final look, then jumps off the bed and quickly leaves the room. Not today.
Making his way back up the hallway, Oscar arrives at Room 313. The door is open, and he proceeds inside. Mrs. K. is resting peacefully in her bed, her breathing steady but shallow. She is surrounded by photographs of her grandchildren and one from her wedding day. Despite these keepsakes, she is alone. Oscar jumps onto her bed and again sniffs the air. He pauses to consider the situation, and then turns around twice before curling up beside Mrs. K.
One hour passes. Oscar waits. A nurse walks into the room to check on her patient. She pauses to note Oscar's presence. Concerned, she hurriedly leaves the room and returns to her desk. She grabs Mrs. K.'s chart off the medical-records rack and begins to make phone calls.
Within a half hour the family starts to arrive. Chairs are brought into the room, where the relatives begin their vigil. The priest is called to deliver last rites. And still, Oscar has not budged, instead purring and gently nuzzling Mrs. K. A young grandson asks his mother, "What is the cat doing here?" The mother, fighting back tears, tells him, "He is here to help Grandma get to heaven." Thirty minutes later, Mrs. K. takes her last earthly breath. With this, Oscar sits up, looks around, then departs the room so quietly that the grieving family barely notices.
On his way back to the charting area, Oscar passes a plaque mounted on the wall. On it is engraved a commendation from a local hospice agency: "For his compassionate hospice care, this plaque is awarded to Oscar the Cat." Oscar takes a quick drink of water and returns to his desk to curl up for a long rest. His day's work is done. There will be no more deaths today, not in Room 310 or in any other room for that matter. After all, no one dies on the third floor unless Oscar pays a visit and stays awhile.
Note: Since he was adopted by staff members as a kitten, Oscar the Cat has had an uncanny ability to predict when residents are about to die. Thus far, he has presided over the deaths of more than 25 residents on the third floor of Steere House Nursing and Rehabilitation Center in Providence, Rhode Island. His mere presence at the bedside is viewed by physicians and nursing home staff as an almost absolute indicator of impending death, allowing staff members to adequately notify families. Oscar has also provided companionship to those who would otherwise have died alone. For his work, he is highly regarded by the physicians and staff at Steere House and by the families of the residents whom he serves.
The Sherpa Says: Perhaps this cat is just "sucking the breath" out of the patients.............
Posted by
Steve Murphy MD
at
1:20 PM
0
comments
Labels: brown university, funny post, gene tests, George Bush, oscar the cat, oscar the grouch, personalized medicine, providence, rhode island
Friday, July 6, 2007
Taking Appointments For August
Posted by
Steve Murphy MD
at
4:41 PM
2
comments
Labels: Breast cancer, Colon cancer, francis collins, future medicine, Helix Health of Connecticut, molecular medicine, personal genome, personalized medicine, pharmacogenomics
Saturday, June 30, 2007
WBUR posts on coumadin and Personalized Medicine!
Despite the heavy Boston accent,
On WBUR Carol's worries regarding Coumadin and Personalized Medicine hit home to millions of patients everywhere. This is an excellent example of the press' coverage of my specialty. Dr Sam Goldhaber a physician at Mass General talks about the promise of pharmacogenomic testing in blood thinning and avoidance of its horrible side effects.
Lastly they interview the Pope of Personalized Medicine
Francis says "Is this the scenario we want personalized medicine to enter?"
"The public thinks that this is snake oil (i.e. Direct to consumer testing and nutrigenomics)"
The Sherpa Says: "Save Betty!!!" We must take the time to educate everyone about the promise and pitfalls of personalized medicine. In My Humble Opinion, the only thing to move physcians will be the slew of lawsuits that happen after we publicize our great outcomes at Helix Health of Connecticut.
Posted by
Steve Murphy MD
at
4:43 PM
2
comments
Labels: coumadin, DNA direct, francis collins, gene doping, gene tests, Harvard, personalized medicine, scienceroll
Monday, June 25, 2007
2 months 3000 visitors!!!!!!
Thank you to everyone who picked up my slack on Sunday. I was unable to post the Medicine 2.0 Carnival because of an illness in the family :(
I would like to tell you how excited I am that I have reached 3000 sets of eyes. I am so invigorated by this whole process of blogging. I love educating the public and physicians and this blog is a labor of love. so thank you to all the readers out there.
Lastly I would like to draw attention to an amazing film director and radio talk show host Kathleen Slattery-Moschkau . She has just produced a new documentary to the medical community called PERx…it is available for viewing via the site www.perxinfo.org The film features internationally renowned experts from Harvard and other orgs. In a short time, continuing education credits will also be available to viewers and the film is also available to the general public. All for free (in order to watch the film, click on “educational modules”)
It is an amazing documentary. She has done others including Side Effects the movie with Grey's Anatomy start Katherine Heigl
Please take the time to watch this documentary as well as Side effects. You will be amazed at what you see.
Take Care
-The Sherpa
Posted by
Steve Murphy MD
at
12:40 PM
3
comments
Labels: gene sherpa, Katherine Heigl, Kathleen Slattery-Moschkau, personalized medicine, PERx, The Gene Sherpa
Friday, June 22, 2007
Harvard Honoring the Sherpa!
Today I was asked to be on the faculty of Harvard's famous Continuing Medical Education conference in the Genetic Basis of Adult Disease. I am extremely honored to be a part of this distinguished faculty. This year's conference will be held October 12-14th. The last conference topics and website are still up and I am certain the new one will be shortly. I highly recommend it for all physicians looking to become Sherpas or at least to stay up with the breakneck pace of genetic discovery in medicine. Several topics include:
- Genetic Causes of Heart Failure
- Genetics of Lipid Disorders
- Genetics of Cardiovascular Disease
- Genetics of Common Psychiatric Diagnoses
- Genetics, Lung Cancer and Treatment Responses
- Genetics of Gastro-Intestinal Diseases
- Barriers to the collection and use of the Family Health History in Primary Care
So who should attend this great conference?
Internal Medicine Docs
Family Physicians
Genetic Counselors
Registered Nurses
Nurse Practitioners
Physician Assistants
I was at the conference last year and am excited to be behind the podium this year. Please mark your calendars!!!!
Posted by
Steve Murphy MD
at
6:02 PM
1 comments
Labels: CME, Colon cancer, drudge report, francis collins, Harvard, internal medicine, Lung cancer, personalized medicine, scienceroll
Wednesday, June 13, 2007
Personalized Medicine since 1986???
Posted by
Steve Murphy MD
at
7:18 PM
2
comments
Labels: DNA direct, francis collins, francis crick, human genome project, JAMA, james watson, personal genome, personalized medicine, preventative medicine, Revolution Health, scienceroll
Saturday, June 9, 2007
Not all drugs benefit all man!
The problems with this type of analysis are threefold.
- The study was too small a size to not need replication
- The study did not involve the genome of the tumors (Perhaps the DNA repair mechanisms in the Caucasian tumors were better. This would like to decreased cell death i.e. response to chemo. As with the tumors and ERCC1)
- The dose of chemo was not controlled (although the lower dose worked better in the Japanese)
The Sherpa Says: In order to make useful sense of Personalized Oncology we must look at genomes of both the cancer and the person. I feel that we are introducing erroneous data to confuse us. I hope The Cancer Genome Atlas will show us some better data!
Posted by
Steve Murphy MD
at
5:14 AM
0
comments
Labels: american, asco, brain cancer, chemotherapy, DNA direct, Eye on DNA, japanese, Lung cancer, personalized medicine, scienceroll
Tuesday, June 5, 2007
Watson, Francis.....and The SHERPA!!!!!
Posted by
Steve Murphy MD
at
4:10 AM
0
comments
Labels: brown university, DNA, DNA direct, francis collins, patrick kennedy, personal genome, personalized medicine, Revolution Health